-
Study aim
-
Comparison of the effects of Fentanyl-Bbupivacaine and Sufentanil-Bbupivacaine
-
Design
-
Clinical trial with a control group, with parallel groups, three blinded, randomized, phase 2 on 105 patients. A lottery will be used for randomization.
-
Settings and conduct
-
This is a three-blind randomized clinical trial conducted on 105 patients candidate for lower limb surgery under spinal anesthesia in Kashani and Al-Zahra hospitals in Isfahan. After the ethics committee's approval and obtaining the patient's consent, the patients are randomly assigned into groups, the desired intervention is applied in each group, and the patient's clinical symptoms are recorded. The researcher who registers and collects data and the data analyst are not aware of the type of intervention applied. although the patients are included in the study, they are not aware of the type of intervention applied and therefore they are all blind.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: patients over 18 years old, candidate for lower limb surgery under spinal anesthesia, ASA anesthesia class I and II, informed consent to participate in the study
Non-entry criteria: infection at the injection site, coagulation disorders, high intracranial pressure, drug addiction, and BMI over 30.
-
Intervention groups
-
Intervention group A: Patients in this group receive 3 ml of Ropivacaine 0.5% along with 25 micrograms of Fentanyl (0.5 CC from the ampoule) for spinal anesthesia.
Intervention group B: Patients in this group receive 3 ml of Ropivacaine 0.5% along with 25 micrograms of Sufentanil (0.5 CC from the ampoule) for spinal anesthesia.
Control group C: Patients in this group receive 3 ml of 0.5% Ropivacaine along with 0.5 CC of distilled Water for spinal anesthesia.
-
Main outcome variables
-
Time of sensory and motor block effect; the time to reach the maximum sensory and motor block; Duration of sensory and motor block